Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADMA Biologics Inc - Common Stock
(NQ:
ADMA
)
17.30
+0.29 (+1.70%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ADMA Biologics Inc - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table
↗
December 28, 2025
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.
Via
The Motley Fool
Topics
Regulatory Compliance
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
↗
December 28, 2025
ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high.
Via
The Motley Fool
Topics
Regulatory Compliance
ADMA Biologics Inc (NASDAQ:ADMA) Emerges as a Top GARP Investment Candidate
↗
December 05, 2025
ADMA Biologics exemplifies GARP investing with strong revenue & earnings growth, high profitability, and a reasonable valuation relative to its biotech peers.
Via
Chartmill
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Is ADMA Biologics Gaining or Losing Market Support?
↗
August 01, 2025
Via
Benzinga
Is ADMA Biologics Gaining or Losing Market Support?
↗
July 02, 2025
Via
Benzinga
How Is The Market Feeling About ADMA Biologics?
↗
June 04, 2025
Via
Benzinga
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
↗
November 01, 2025
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
Via
The Motley Fool
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
August 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 07, 2025
Via
Benzinga
Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
↗
August 07, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
ADMA Biologics Earnings Preview
↗
May 06, 2025
Via
Benzinga
Adma Biologics (ADMA) Q2 Revenue Up 14%
↗
August 06, 2025
Via
The Motley Fool
Topics
Economy
ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria
↗
June 13, 2025
ADMA Biologics (NASDAQ:ADMA) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential
↗
June 09, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong growth fundamentals and a technical breakout setup, making it a stock to watch in the biotech sector.
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup
↗
June 07, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout...
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Promising Affordable Growth Stock
↗
June 03, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong growth, reasonable valuation, and solid financial health, making it an attractive candidate for investors seeking affordable growth stocks in the biotech...
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing.
↗
May 09, 2025
Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...
Via
Chartmill
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings
↗
May 08, 2025
Via
Benzinga
Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits
↗
May 08, 2025
The company makes immunoglobulin products using donated plasma.
Via
Investor's Business Daily
Topics
Earnings
3 Mid-Cap Medical Stocks Outperforming the Market
May 06, 2025
Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.
Via
MarketBeat
Topics
Economy
Should you consider ADMA BIOLOGICS INC (NASDAQ:ADMA) for growth investing?
↗
May 05, 2025
A fundamental analysis of (NASDAQ:ADMA): Exploring growth characteristics of ADMA BIOLOGICS INC (NASDAQ:ADMA).
Via
Chartmill
Would Mark Minervini consider ADMA BIOLOGICS INC (NASDAQ:ADMA) a top stock pick?
↗
May 01, 2025
A fundamental and technical analysis of (NASDAQ:ADMA): Exploring ADMA BIOLOGICS INC (NASDAQ:ADMA)'s high growth characteristics.
Via
Chartmill
ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate
↗
May 01, 2025
ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate
Via
Chartmill
What's Going On With ADMA Stock Monday?
↗
April 28, 2025
ADM shares are trading higher Monday after the company announced the FDA's approval of its yield enhancement process.
Via
Benzinga
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday
↗
April 28, 2025
Via
Benzinga
IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval
↗
April 28, 2025
The company says a new process will improve its output by 20%, benefitting revenue and earnings later this year.
Via
Investor's Business Daily
Why ADMA BIOLOGICS INC (NASDAQ:ADMA) qualifies as a high growth stock.
↗
April 23, 2025
A fundamental and technical analysis of (NASDAQ:ADMA): Is ADMA BIOLOGICS INC (NASDAQ:ADMA) suited for high growth investing?
Via
Chartmill
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
